CAJ | 학술논문

目的：观察甲基强的松龙+低分子肝素治疗原发性肾病综合征的临床疗效。方法选取肾病综合征患者56例,随机分为A、B两组,A组予以甲强龙(甲强龙琥珀酸钠)40mg,静脉滴注,1次/d,同时配以低分子肝素治疗,B组予以泼尼松1mg/(kg·d),晨起顿服,配以潘生丁50~75mg,3次/d。结果 A组治疗效果均优于B组(P<0．05),A组不良反应少于B组。结论甲强龙+低分子肝素治疗原发性肾病综合征起效快,疗效好,不良反应少。
목적：관찰갑기강적송룡+저분자간소치료원발성신병종합정적림상료효。방법선취신병종합정환자56례,수궤분위A、B량조,A조여이갑강룡(갑강룡호박산납)40mg,정맥적주,1차/d,동시배이저분자간소치료,B조여이발니송1mg/(kg·d),신기돈복,배이반생정50~75mg,3차/d。결과 A조치료효과균우우B조(P<0．05),A조불량반응소우B조。결론갑강룡+저분자간소치료원발성신병종합정기효쾌,료효호,불량반응소。
Objective To investigate the clinical efficacy of primary nephrotic syndrome methylprednisolone + low mo-lecular weight heparin. Methods 56 cases of patients with nephrotic syndrome were randomly divided into A, B groups, A group received methylprednisolone (methylprednisolone sodium succinate) 40mg once daily intravenous infusion, while accompanied by low molecular weight heparin therapy, group B to be prednisone 1mg /( kg·d), early morning Dayton clothing, with dipyri-damole 50mg-75mg, Tid, Po. Results A treatment group was better than group B (P<0. 05), A group of adverse reactions than group B. Conclusion methylprednisolone + LMWH treatment of primary nephrotic syndrome rapid onset of efficacy, fewer adverse reactions.